Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.88B |
| 2 |
Pfizer
PFE
|
+$1.41B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.17B |
| 4 |
Cisco
CSCO
|
+$1.1B |
| 5 |
Novartis
NVS
|
+$984M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.21B |
| 2 |
Adobe
ADBE
|
+$1.06B |
| 3 |
Stryker
SYK
|
+$955M |
| 4 |
Boston Scientific
BSX
|
+$695M |
| 5 |
Banco Santander
SAN
|
+$684M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.16% |
| 2 | Financials | 17.3% |
| 3 | Industrials | 10.45% |
| 4 | Healthcare | 9.91% |
| 5 | Energy | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
SS&C Technologies
SSNC
$18.1B
| $9.44M | ﹤0.01% |
139,701
-19,023
| -12% | -$1.46M |
|
402
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
| $9.21M | ﹤0.01% |
150,333
+13,364
| +10% | +$717K |
|
403
iShares ESG Aware MSCI USA ETF
ESGU
$17.9B
| $9.19M | ﹤0.01% |
64,963
+560
| +0.9% | +$82.8K |
|
404
Williams-Sonoma
WSM
$26.9B
| $8.99M | ﹤0.01% |
49,303
-2,322
| -4% | -$464K |
|
405
First Interstate BancSystem
FIBK
$3.69B
| $8.88M | ﹤0.01% |
265,957
+63
| +0% | +$2.25K |
|
406
Crescent Energy
CRGY
$3.79B
| $8.75M | ﹤0.01% |
648,068
-19,005
| -3% | -$199K |
|
407
Rayonier
RYN
$6.55B
| $8.69M | ﹤0.01% |
+421,641
| New | +$9.29M |
|
408
Mirum Pharmaceuticals
MIRM
$6.46B
| $8.6M | ﹤0.01% |
93,109
+79,020
| +561% | +$7.43M |
|
409
ENI
E
$80.5B
| $8.45M | ﹤0.01% |
149,182
-3,426
| -2% | -$154K |
|
410
Hewlett Packard
HPE
$63.4B
| $8.37M | ﹤0.01% |
351,392
-1,123
| -0.3% | -$24.9K |
|
411
Altria Group
MO
$114B
| $8.28M | ﹤0.01% |
125,545
+5,023
| +4% | +$323K |
|
412
Valero Energy
VLO
$90.1B
| $8.09M | ﹤0.01% |
32,729
+5,390
| +20% | +$1.11M |
|
413
General Motors
GM
$80.4B
| $8.03M | ﹤0.01% |
107,820
-5,118
| -5% | -$407K |
|
414
Bentley Systems
BSY
$10.8B
| $7.96M | ﹤0.01% |
226,720
+110
| +0% | +$4.04K |
|
415
Micron Technology
MU
$930B
| $7.88M | ﹤0.01% |
23,338
-30,192
| -56% | -$11.8M |
|
416
iShares Core S&P 500 ETF
IVV
$878B
| $7.79M | ﹤0.01% |
11,921
+4,819
| +68% | +$3.29M |
|
417
Worthington Steel
WS
$1.83B
| $7.77M | ﹤0.01% |
255,936
+17,598
| +7% | +$682K |
|
418
M&T Bank
MTB
$35.7B
| $7.73M | ﹤0.01% |
37,405
-1,789
| -5% | -$385K |
|
|
ONT
419
Onterris Inc
ONT
$759M
| $7.72M | ﹤0.01% |
352,569
| – | – |
|
420
NNN REIT
NNN
$9.04B
| $7.63M | ﹤0.01% |
181,500
+82,283
| +83% | +$3.55M |
|
421
Independent Bank
INDB
$3.99B
| $7.45M | ﹤0.01% |
99,020
-6,610
| -6% | -$518K |
|
422
Citizens Financial Group
CFG
$30.3B
| $7.42M | ﹤0.01% |
123,724
-4,700
| -4% | -$289K |
|
423
Paycom
PAYC
$7.64B
| $7.34M | ﹤0.01% |
60,362
-6,780
| -10% | -$907K |
|
424
Intel
INTC
$455B
| $7.33M | ﹤0.01% |
166,209
+15,604
| +10% | +$715K |
|
425
Federal Realty Investment Trust
FRT
$10.7B
| $7.29M | ﹤0.01% |
68,648
+12,941
| +23% | +$1.35M |
|
Similar funds
Ken Fisher's Q1 2026 Portfolio in Review
As of Q1 2026, Ken Fisher held 1,133 positions worth $295B, up 0.65% from $293B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Fisher's Q1 2026 filing shows 116 new, 416 increased, 461 reduced and 117 closed positions. Its largest new stake was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M. The largest sale was Abbott, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Ken Fisher's largest Q1 2026 buy was Portfolio Building Block World Pharma and Biotech Index ETF: 28,040,859 shares worth $717M.
- Ken Fisher added most to AbbVie in Q1 2026, an estimated $1.88B increase.
- Ken Fisher's biggest Q1 2026 reduction was Abbott, cutting an estimated $1.21B.
- Ken Fisher fully exited Trip.com Group in Q1 2026, selling an estimated $175M.
- Ken Fisher's ten largest holdings make up 33% of its $295B portfolio in Q1 2026.
- Ken Fisher opened 116 new positions and closed 117 in Q1 2026.
- Ken Fisher's portfolio value rose 0.65% quarter-over-quarter to $295B.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.